Showing results (881-890 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|May 3, 2024
Identification and outcomes of KDIGO-defined chronic kidney disease in 1.4 million U.S. Veterans with heart failureSamir S Patel, Venkatesh K Raman, Sijian Zhang, et al.
European Journal of Heart Failure|May 3, 2024
Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fractionMingming Yang, Toru Kondo, Atefeh Talebi, et al.
European Journal of Heart Failure|April 29, 2024
Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESCAmina Rakisheva, Karen Sliwa, Johann Bauersachs, et al.
European Journal of Heart Failure|April 29, 2024
Differential sex-related effect of left ventricular ejection fraction trajectory on the risk of mortality and heart failure readmission following hospitalization for acute heart failure: A longitudinal studyEduardo Núñez, Enrique Santas, Hector Merenciano, et al.
European Journal of Heart Failure|May 30, 2024
Residual tricuspid regurgitation after tricuspid transcatheter edge-to-edge repair: Insights into the EuroTR registryLukas Stolz, Karl-Patrik Kresoja, Jennifer von Stein, et al.
European Journal of Heart Failure|June 5, 2024
Pulmonary hypertension across the spectrum of left heart and lung diseaseBarry A Borlaug, Brett Larive, Robert P Frantz, et al.
European Journal of Heart Failure|June 5, 2024
Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA)Domingo Pascual-Figal, Julio Núñez Villota, Maria Teresa Pérez-Martínez, et al.
European Journal of Heart Failure|June 6, 2024
Prognostic utility of cardiopulmonary exercise testing with simultaneous exercise echocardiography in heart failure with preserved ejection fractionAyami Naito, Kazuki Kagami, Naoki Yuasa, et al.
European Journal of Heart Failure|May 11, 2024
Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID-19 infection: The PARACOR-19 randomized clinical trialStephen J Greene, RaKavius Chambers, Joseph B Lerman, et al.
European Journal of Heart Failure|May 11, 2024
New York Heart Association functional class and implantable cardioverter-defibrillator in non-ischaemic heart failure with reduced ejection fraction: Extended follow-up of the DANISH trialMunise N Karacan, Seiko N Doi, Adelina Yafasova, et al.
Pageof 398